Rybelsus®

Rybelsus
Manufacturer: Novo Nordisk India Pvt Ltd

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.

3mg

Package Savings Per tablet Price Order
90 tablets lei 2009.85 lei 67.05 lei 6034.68
  • Free AirMail shipping
60 tablets lei 1071.75 lei 71.52 lei 4291.26
  • Free AirMail shipping
30 tablets lei 401.88 lei 75.99 lei 2279.63
  • Free AirMail shipping
20 tablets lei 178.59 lei 80.45 lei 1609.08
  • Free AirMail shipping
10 tablets lei 89.38 lei 893.84
  • Free AirMail shipping

7mg

Package Savings Per tablet Price Order
90 tablets lei 802.87 lei 80.46 lei 7241.66
  • Free AirMail shipping
60 tablets lei 401.21 lei 82.70 lei 4961.81
  • Free AirMail shipping
30 tablets lei 133.66 lei 84.93 lei 2547.85
  • Free AirMail shipping
20 tablets lei 44.48 lei 87.16 lei 1743.19
  • Free AirMail shipping
10 tablets lei 89.38 lei 893.84
  • Free AirMail shipping

14mg

Package Savings Per tablet Price Order
90 tablets lei 1004.03 lei 96.11 lei 8649.81
  • Free AirMail shipping
60 tablets lei 535.32 lei 98.34 lei 5900.57
  • Free AirMail shipping
30 tablets lei 200.72 lei 100.57 lei 3017.23
  • Free AirMail shipping
20 tablets lei 89.18 lei 102.81 lei 2056.11
  • Free AirMail shipping
10 tablets lei 107.26 lei 1072.65
  • Free AirMail shipping

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.